Patents by Inventor Xintao ZHAO

Xintao ZHAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250154149
    Abstract: The present invention relates to a pharmaceutical composition comprising a compound as shown in formula I, and use of the pharmaceutical composition in treating diseases. The present invention also relates to a method for preparing the compound as shown in formula I.
    Type: Application
    Filed: February 14, 2023
    Publication date: May 15, 2025
    Applicant: Betta Pharmaceuticals Co., Ltd.
    Inventors: Xiaofeng XU, Xizhen SONG, Xintao ZHAO, Yan XU, Liang CHEN, Hongfei RONG, Zongquan LI, Xiangyong LIU, Lieming DING, Jiabing WANG
  • Publication number: 20240246994
    Abstract: Disclosed are a polymorph of (S)-1-(2-((S)-3-cyclopropyl-5-isopropyl-2,4-dioxoimidazolidin-1-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)pyrrolidine-2-carboxamide, a composition comprising the polymorph, a use method therefor and a preparation method therefor.
    Type: Application
    Filed: May 12, 2022
    Publication date: July 25, 2024
    Applicant: Betta Pharmaceuticals Co., Ltd.
    Inventors: Houxian ZU, Liang CHEN, Xizhen SONG, Xintao ZHAO, Kai CHEN, Xiaoyun LIU, Jin WANG, Zhifang XIA, Ying XU, Yuanzheng ZHOU, Lieming DING, Jiabing WANG
  • Publication number: 20240213538
    Abstract: A non-aqueous electrolyte and a lithium-ion battery containing the non-aqueous electrolyte. The non-aqueous electrolyte contains a lithium salt, an organic solvent, and an additive. The additive contains 2-phenyl-benzothiazole and a derivative thereof, and can form a passive film on the surface of a positive electrode when a lithium-ion battery is overcharged, so as to prevent the voltage of the battery from further increasing during overcharging; the additive makes the temperature of the electrolyte rise slower during overcharging; and the addition of the additive not only do not affect the room temperature cycle performance of the lithium-ion battery, but also can even improve the room temperature cycle performance of the lithium-ion battery, thereby effectively avoiding the potential safety hazards caused by battery overcharging.
    Type: Application
    Filed: March 9, 2022
    Publication date: June 27, 2024
    Inventors: Linpo YU, Xintao ZHAO, Kaichen XU, Zhitao WANG, Chunyan LIU, Chaolun GAN
  • Patent number: 11466013
    Abstract: Disclosed are a compound (as shown in formula I) as an extracellular signal-regulated kinase (ERK) inhibitor, a pharmaceutical composition thereof, a preparation method therefor, and use thereof in treating ERK-mediated diseases. Said compound plays a role by regulating a plurality of processes such as cell proliferation, apoptosis, migration and angiogenesis.
    Type: Grant
    Filed: June 6, 2019
    Date of Patent: October 11, 2022
    Assignee: Betta Pharmaceuticals Co., Ltd
    Inventors: Hao Wu, Wei Gu, Xiaojing Tang, Wei Wang, Bo Zhan, Dongjie Feng, Yongxin Ke, Zhongyan Chen, Yifei Shen, Wenmao Wu, Xintao Zhao, Hong Lan, Jiabing Wang, Lieming Ding
  • Publication number: 20210261552
    Abstract: Disclosed are a compound (as shown in formula I) as an extracellular signal-regulated kinase (ERK) inhibitor, a pharmaceutical composition thereof, a preparation method therefor, and use thereof in treating ERK-mediated diseases. Said compound plays a role by regulating a plurality of processes such as cell proliferation, apoptosis, migration and angiogenesis.
    Type: Application
    Filed: June 6, 2019
    Publication date: August 26, 2021
    Applicant: Betta Pharmaceuticals Co., LTD
    Inventors: Hao WU, Wei GU, Xiaojing TANG, Wei WANG, Bo ZHAN, Dongjie FENG, Yongxin KE, Zhongyan CHEN, Yifei SHEN, Wenmao WU, Xintao ZHAO, Hong LAN, Jiabing WANG, Lieming DING